SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-043904
Filing Date
2012-08-09
Accepted
2012-08-09 12:34:20
Documents
7
Period of Report
2012-08-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v320664_8k.htm 8-K 33483
2 EXCLUSIVE CHANNEL COLLABORATION AGREEMENT v320664_ex10-1.htm EX-10.1 387096
3 STOCK ISSUANCE AGREEMENT v320664_ex10-2.htm EX-10.2 161620
4 FIRST AMENDMENT TO REGISTRATION RIGHTS AGREEMENT v320664_ex10-3.htm EX-10.3 19689
5 PRESS RELEASE v320664_ex99-1.htm EX-99.1 21793
6 GRAPHIC image_001.jpg GRAPHIC 4003
7 GRAPHIC image_001.gif GRAPHIC 3242
  Complete submission text file 0001144204-12-043904.txt   635471
Mailing Address 3985 RESEARCH PARK DRIVE, SUITE 200 ANN ARBOR MI 48108
Business Address 3985 RESEARCH PARK DRIVE, SUITE 200 ANN ARBOR MI 48108 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 121019434
SIC: 2834 Pharmaceutical Preparations